We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.9M
AUM Growth
-$128K
Cap. Flow
-$190K
Cap. Flow %
-6.53%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NMTC icon
NeuroOne Medical Technologies
NMTC
+$145K
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$44.1K

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.52%
2 Healthcare 28.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACWI icon
1
iShares MSCI ACWI ETF
ACWI
$33.3B
$2.08M 71.52%
17,359
– –
ZNTL icon
2
Zentalis Pharmaceuticals
ZNTL
$357M
$644K 22.19%
175,000
-12,143
-6% -$44.1K
UBX
3
DELISTED
Unity Biotechnology
UBX
$182K 6.29%
124,081
– –
NMTC icon
4
NeuroOne Medical Technologies
NMTC
$16.7M
– –
-30,292
Closed -$145K

Similar funds

SWS
SYSTM Wealth Solutions Chicago, Illinois $3.29M AUM 31.67% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

Mayo Clinic's Q3 2024 Portfolio in Review

As of Q3 2024, Mayo Clinic held 4 positions worth $2.9M, down 4.2% from $3.03M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic withdrew a net $190K in Q3 2024, closing 1 position and reducing 1 holding. Its most notable exit was NeuroOne Medical Technologies, an estimated $145K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, up from 64% a quarter earlier, followed by Healthcare.

  • Mayo Clinic's biggest Q3 2024 reduction was Zentalis Pharmaceuticals, cutting an estimated $44.1K.
  • Mayo Clinic fully exited NeuroOne Medical Technologies in Q3 2024, selling an estimated $145K.
  • Mayo Clinic's ten largest holdings make up 100% of its $2.9M portfolio in Q3 2024.
  • Mayo Clinic opened 0 new positions and closed 1 in Q3 2024.
  • Mayo Clinic's portfolio value fell 4.2% quarter-over-quarter to $2.9M.

Based on Mayo Clinic's 13F filing for Q3 2024, filed 12 Nov 2024.